« PreviousContinue »
as BII Leicht edir asmr
TGE ESSE * * * కాగా 2: Sai Naaku ne Nee 39 s gume. Is ges nderser start
2 nedes Deus se seeds I see B E D responsible for
en gaasipoesii De zade me sens bet I SI Cened about that any das very rade X - poa Doa, & pebis danos y under redes c seceras ou people a laaring in its wate oss
The cy Faso restore pebbe trust is tans into this program and Ead out a wedi Tong I Agrl Secretary camane si Dowed a napon azidon prostar. We must learn from our mistatss in the pas de ore we idazurate a new immuniston drive
I think the side fu program was the Federal Government's "Voor Dick" I think it was a great white whale that we pursued so doszed that commonsense pas lost sight of. The prgtam was a terrible waste.
We thought it would cost $:35 million, but it looks now like it will cost is er over . 53on.
We thought a national immunization program would draw us all together in a national effort. This was to be a model for future immunization programs. Instead, we squandered the precious trust the public accords us.
Do you know what could be done with a $1 billion. We would provide all poor children with dental care. We could screen por children for signs of mental retardation at an age when such a handicap is most easily treated. Can you conceive of how $1 billion could help programs for the handicapped of our Nation. Or how it could be used to modernize our veterans hospitals?
When I think what could be done with the funds we now must devote to cleaning up after the swine flu program I feel frustrated With all our expertise, why didn't we know better?
I hope we can get answers to some of these questions in this hearing, and I want to thank the chairman for calling these hear ings so that we can look into the issue of the swine flu immunization program.
Mr. ROGERS. Mr. Maquire, did you have a statement?
Mr. ROGERS. We are pleased to have as our first witnesses the representatives of the General Accounting Office, who conducted the study requested by the committee. The witnesses are Mr. Gregory J. Ahart, Director of the Human Resources Division, General Accounting Office, who is accompanied by Jesse Flowers, Michael Burnett, and Peter Oswald, supervisory auditors of the General Accounting Office.
We welcome all of you gentlemen here. Your statement will be made a part of the record in full at this point and you may proceed as desired.
COMMITTEE ON INTERSTATE AND FOREIGN COMMERCE
HARLEY O. STAGGERS, West Virginia, Chairman JOHN E. MOSS, California
SAMUEL L. DEVINE, Ohio JOHN D. DINGELL, Michigan
JAMES T. BROYHILL, North Carolina PAUL G. ROGERS, Florida
TIM LEE CARTER, Kentucky LIONEL VAN DEERLIN, California
CLARENCE J. BROWN, Ohio FRED B. ROONEY, Pennsylvania
JOE SKUBITZ, Kansas JOHN M. MURPHY, New York
JAMES M. COLLINS, Texas DAVID E. SATTERFIELD III, Virginia
LOUIS FREY, JR., Florida BOB ECKHARDT, Texas
NORMAN F. LENT, New York RICHARDSON PREYER, North Carolina EDWARD R. MADIGAN, Illinois CHARLES J. CARNEY, Ohio
CARLOS J. MOORHEAD, California RALPH H. METCALFE, Illinois
MATTHEW J. RINALDO, New Jersey JAMES H. SCHEUER, New York
W. HENSON MOORE, Louisiana RICHARD L. OTTINGER, New York
DAVE STOCKMAN, Michigan
MARC L. MARKS, Pennsylvania
W. E. WILLIAMSON, Chief Clerk and Staff Director
CHRISTOPHER E. DUNNE
WILLIAM M. KITZMILLER
MARK J. RAABE
THOMAS M. RYAN
RICHARD D. LINDSAY, M.D.
PAUL G. ROGERS, Florida, Chairman
TIM LEE CARTER, Kentucky RICHARDSON PREYER, North Carolina JAMES T. BROYHILL, North Carolina JAMES H. SCHEUER, New York
EDWARD R. MADIGAN, Illinois HENRY A. WAXMAN, California
JOE SKUBITZ, Kansas
SAMUEL L. DEVINE, Ohio (Ex Officio)
STEPHAN E. LAWTON, Counsel
Jo ANNE GLISSON, Senior Staff Associate
WILLIAM V. CORR, Assistant Counsel
BURKE ZIMMERMAN, Research Assistant
tion Morri Oswal Peters
Page Abramson, Clarence A., senior counsel, Merck & Co. Inc
411 Ahart, Gregory J., Director, Human Resources Division, General Accoun ing Office
4 Bailey, William O., president, Aetna Life & Casualty
438, 487 Biery, Richard M., M.D., on behalf of the United States Conference of City Health Officers
397 Bradford, Windell, Administrative Assistant to Dr. Millar, Bureau of State
Services, Center for Disease Control, Public Health Service, Department
37, 96 Burnett, Michael, Supervisory Auditor, General Accounting Office
4 Elsea, William R., M.D., vice president, National Association of County Health Officials (NACHO).
384 Flowers, Jesse, Supervisory Auditor, General Accounting Office
4 Gemmell, Mike, legislative representative, National Association of County Health Officials (NACHO).
384 Goldbloom Irwin, Deputy Assistant Attorney General, Civil Division, Department of Justice
68 Hagan, Charles F., general counsel, American Home Products Corp .411, 418 Harder, Henry U., president, Chubb & Son, Inc
438 Hendrickson, Robert F., vice president, operations, Merck Sharp & Dohme Division, Merck & Co., Inc....
411 Jones, T. Lawrence, president, American Insurance Association.
438 Jordan, William, M.D., National Institute of Allergy and Infectious Diseases, Department of Health, Education, and Welfare
..... 37, 96 Lamb, Frederick D., vice president and legal counsel, Merrell-National Laboratories
.411, 426 Lloyd, Douglas S., M.D., on behalf of the Association of State and Territorial Health Officials (ASTHO)
379 Markoe, Frank, Jr., vice chairman, Board of Directors, Warner-Lambert Co. (Parke-Davis)
.411, 418 Meyer, Harry M., Jr., M.D., Director, Bureau of Biologics, Food and Drug Administration, Department of Health, Education, and Welfare
37, 96 Millar, J. Donald, M.D., Director, Bureau of State Services, Center for
Disease Control, Public Health Service, Department of Health, Educa-
37, 96 Morris, J. Anthony, Ph. D., Greenbelt, Md
406 Oswald, Peter, Supervisory Auditor, General Accounting Office
4 Peterson, Neil R., Assistant Chief, Torts Section, Civil Division, Department of Justice
68 Additional material submitted for the record byAmerican Insurance Association: Attachments to Mr. Jones' prepared statement: Insurance proposals-alternative No. 1, 2, and 3
450 Secretary Mathews' (HEW) telex to insurance companies dated July 29, 1976
453 Swine flu vaccine program
454 Memorandum dated November 10, 1976, to each subscribing
insurer-special liability insurance and special excess liability
464 Servicing carrier agreement for insurers of the manufacturers of vaccine
Additional material submitted for the record by-Continued
to Chairman Rogers re correspondence concerning the scope of study;
Figure 1-Percent of persons with history of receiving influenza
and unvaccinated groups by age, United States, October
>17 years of age, by week of onset after A/New Jersey
> 17 years of age, by week of onset after A/New Jersey influenza
vaccination, United States, October 1976-January 1977.......... 64 Audit reports
350 “Evaluation and control of vaccines for the national influenza immunization program," report by Barry, et al
105 Table 4-Hemagglutinin content of A/New Jersey component of
influenza vaccines as determined by immunoelectrophoresis ...... 106 Table 5-Amount of vaccine as of December 16, 1976
107 Testing and distribution chart by doses and week ending
Califano re additional written questions with subsequent replies
status of the self insurance retention fund; 2. production of "Shope"
influenza virus vaccine; and 3. waiver of cost accounting standards. 110
Justice re status of the 28 positions funded by a supplemental
tant Attorney General to Chairman Rogers re list of all personnel in
tant Attorney General to Chairman Rogers re cost per claim of
82 National Association of County Health Officials (NACHO), attachment to
Dr. Elsea's prepared statement: NACHO survey on selected counties'
392 Statement submitted for the record by
Public Citizen's Health Research Group, Anita Johnson and Sidney Wolfe,
Appendix—“The Swine Flu Program: An Unprecedented Venture in Preven- Page tive Medicine,” report to the Congress by the Comptroller General of the United States June 27, 1977
Ahart, Gregory J., Director, Human Resources Division.
Oswald, Peter, Supervisory Auditor.
Bradford, Windell, Administrative Assistant to Dr. Millar, Bureau of State
Services, Center for Disease Control, Public Health Service. Jordan, William, M.D., National Institute of Allergy and Infectious Diseases. Meyer, Harry M., Jr., M.D., Director, Bureau of Biologics, Food and Drug
Administration. Millar, J. Donald, M.D., Director, Bureau of State Services, Center for Disease
Control, Public Health Service. Justice Department:
Goldbloom, Irwin, Deputy Assistant Attorney General, Civil Division.
Peterson, Neil R., Assistant Chief, Torts Section, Civil Division.
Abramson, Clarence A., senior counsel.
Elsea, William R., M.D., vice president.
Gemmell, Mike, legislative representative.